Skip to content

Treatments for Benign Paroxysmal Positional Vertigo (BPPV)

Treatments for Benign Paroxysmal Positional Vertigo (BPPV)

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000359
Enrollment
150
Registered
1999-11-03
Start date
1998-10-31
Completion date
2003-06-30
Last updated
2012-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertigo

Keywords

Physical Therapy, Vertigo, rehabilitation, occupational therapy

Brief summary

The purpose of this study was to determine the relative short- and long-term efficacy of several physical treatment paradigms commonly employed for the treatment of benign paroxysmal positional vertigo (BPPV), including the canalith repositioning (Epley) maneuver, the liberatory (Semont) maneuver, the Brandt-Daroff exercises and nonspecific vestibular habituation exercises. These procedures involve exercises and head manipulations. Vertigo intensity and frequency, the presence/absence of slow-phase eye movements, the degree of dizziness handicap and acts of daily living (ADL) were assessed. The study also ascertained the effects of co-morbid conditions on the response to treatment. While BPPV is a common and significant public health problem that has been recognized for several decades, this is the first systematic study of the relative treatment efficacy of different physical treatment modalities for this disorder.

Interventions

BEHAVIORALCanalith repositioning maneuver (Epley maneuver)

Standard passive motion of the head: Dix-Hallpike maneuver, turn head to opposite side, roll over, sit up.

BEHAVIORALSemont maneuver

Sidelying maneuver, flip over 180 deg, sit up.

Active exercise. Sidelying to involved side, sidelying to uninvolved side, sit up.

Head shaking exercises in pitch, roll, yaw and circumduction. Titrating from 2 repetitions per exercise to 20 repetitions per exercise, as tolerated.

BEHAVIORALShamManeuver

Passive movement of the head

Sponsors

National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients may be eligible for this study if they: * Are at least 21 years old. * Have a diagnosis of unilateral posterior semicircular canal BPPV according to established clinical test criteria. * Have functional to normal range of motion of the neck and the back.

Exclusion criteria

Patients will not be eligible for this study if they: * Have a history of prior ear surgery or prior treatment for BPPV. * Have an orthopedic or connective tissue disorder that impairs functional neck or trunk range of motion. * Have a significant neurological disorder or spinal cord damage. * Are on vestibular suppressant medications. * Have Meniere's disease or acoustic neuromas.

Design outcomes

Primary

MeasureTime frame
Vertigo6 month s

Secondary

MeasureTime frame
Balance6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026